Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Carr

Showing results (381-390 of 461) with videos related to

Pageof 47
Sort By:
Birth Defects Original Article Series|January 1, 1978
Neuropsychiatric involvement in systemic lupus erythematosusR I Carr, D W Shucard, S A Hoffman, et al.
Archives of Dermatology|November 1, 1972
Anti-native DNA antibodies in discoid lupus erythematosusM J Mandel, R I Carr, W L Weston, et al.
BMC Cancer|June 3, 2014
Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell linesRosalba D'Alessandro, Maria G Refolo, Catia Lippolis, et al.
Investigational New Drugs|May 4, 2005
Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancyDean Lim, Robert J Morgan, Steven Akman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 3, 2014
Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablationAntonio Facciorusso, Valentina Del Prete, Matteo Antonino, et al.
Journal of Gastroenterology and Hepatology|April 16, 2014
Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablationAntonio Facciorusso, Valentina Del Prete, Matteo Antonino, et al.
Life Sciences|May 11, 2002
Vitamin K uptake in hepatocytes and hepatoma cellsZhong-Qian Li, Feng-Yun He, Christine J Stehle, et al.
Clinical Oncology|December 1, 1979
Hodgkin's disease in Sheffield (1971--76) (with computer analysis of variables)B W Hancock, M Aitken, J F Martin, et al.
Biochemistry|September 3, 2003
Binding and inhibition of Cdc25 phosphatases by vitamin K analoguesSiddhartha Kar, Iliya M Lefterov, Meifang Wang, et al.
Molecular Cancer Research : MCR|September 26, 2019
Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814Qing Sun, Yige Guo, Xiaohong Liu, et al.
Pageof 47

Showing results (381-390 of 461) with videos related to

Sort By:
Pageof 47
Birth Defects Original Article Series|January 1, 1978
Neuropsychiatric involvement in systemic lupus erythematosusR I Carr, D W Shucard, S A Hoffman, et al.
Archives of Dermatology|November 1, 1972
Anti-native DNA antibodies in discoid lupus erythematosusM J Mandel, R I Carr, W L Weston, et al.
BMC Cancer|June 3, 2014
Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell linesRosalba D'Alessandro, Maria G Refolo, Catia Lippolis, et al.
Investigational New Drugs|May 4, 2005
Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancyDean Lim, Robert J Morgan, Steven Akman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 3, 2014
Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablationAntonio Facciorusso, Valentina Del Prete, Matteo Antonino, et al.
Journal of Gastroenterology and Hepatology|April 16, 2014
Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablationAntonio Facciorusso, Valentina Del Prete, Matteo Antonino, et al.
Life Sciences|May 11, 2002
Vitamin K uptake in hepatocytes and hepatoma cellsZhong-Qian Li, Feng-Yun He, Christine J Stehle, et al.
Clinical Oncology|December 1, 1979
Hodgkin's disease in Sheffield (1971--76) (with computer analysis of variables)B W Hancock, M Aitken, J F Martin, et al.
Biochemistry|September 3, 2003
Binding and inhibition of Cdc25 phosphatases by vitamin K analoguesSiddhartha Kar, Iliya M Lefterov, Meifang Wang, et al.
Molecular Cancer Research : MCR|September 26, 2019
Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814Qing Sun, Yige Guo, Xiaohong Liu, et al.
Pageof 47